Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.
Verge Genomics is a company that develops a drug discovery platform for neurodegenerative diseases. It was founded in 2015 by Alice Zhang and Jason Chen. Verge Genomics has received funding from OS Fund, WuXi AppTec, and ALS Investment Fund. The company is headquartered in San Francisco, California, United States.